If you are wondering whether DaVita’s current share price is giving you fair value or a possible bargain, looking closely at how the market is pricing the business can be a useful next step.
Recently, the stock closed at US$106.30, with a 2.3% gain over the last 7 days, a 8.8% decline over the last 30 days, a 7.2% decline year to date, and a 36.9% decline over the last year. The 3 year return is 37.2% and the 5 year return is a 9.8% decline.
These mixed short and long term returns sit against an ongoing flow of sector and policy headlines for healthcare providers, which can influence how investors think about dialysis operators like DaVita. Each piece of news may move sentiment in the short term. The key question for you is whether the…
